Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00564_DB06684_nanopub.RAm_dVDIF1TGFMhLlRESyr6RbYWzLJ2F5Nq6ql4CyzytM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00564_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00564_DB06684 label "DDI between Carbamazepine and Vilazodone - Carbamazepine may increase the metabolism of Selective Serotonin Reuptake Inhibitors (SSRI). Specifically those agents metabolized via CYP1A2, 2C, and/or 3A4 isoenzymes. Selective Serotonin Reuptake Inhibitors may decrease the metabolism of Carbamazepine. Specifically those SSRIs that inhibit CYP3A4 isoenzymes. [drugbank_resource:DB00564_DB06684]" assertion.
- drugbank_resource:DB00564_DB06684 identifier "drugbank_resource:DB00564_DB06684" assertion.
- drugbank_resource:DB00564_DB06684 title "DDI between Carbamazepine and Vilazodone - Carbamazepine may increase the metabolism of Selective Serotonin Reuptake Inhibitors (SSRI). Specifically those agents metabolized via CYP1A2, 2C, and/or 3A4 isoenzymes. Selective Serotonin Reuptake Inhibitors may decrease the metabolism of Carbamazepine. Specifically those SSRIs that inhibit CYP3A4 isoenzymes." assertion.
- drugbank:DB00564 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB06684 assertion.
- drugbank:DB06684 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB06684 assertion.